Dupuytren disease: Anatomy, pathology, presentation, and treatment.
about
Connective Tissue Degeneration: Mechanisms of Palmar Fascia Degeneration (Dupuytren's Disease)Imaging features of superficial and deep fibromatoses in the adult population.Surgical complications associated with fasciectomy for dupuytren's disease: a 20-year review of the English literature.Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren's cords: an exploratory studyGenome-wide association scan of Dupuytren's disease.Late complications of clinical clostridium histolyticum collagenase use in Dupuytren's diseaseThe incidence of postoperative flare reaction and tissue complications in Dupuytren's disease using tension-free immobilization.Postapproval clinical experience in the treatment of Dupuytren's contracture with collagenase clostridium histolyticum (CCH): the first 1,000 daysAnti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblastsGenome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's diseasePrevalence, incidence, and treatments of Dupuytren's disease in the United States: results from a population-based studyElevated transforming growth factor β and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblastsClinical outcomes following collagenase injections compared to fasciectomy in the treatment of Dupuytren's contractureRecent Surgical and Medical Advances in the Treatment of Dupuytren's Disease - A Systematic Review of the LiteratureDupuytren's: a systems biology disease.Systematic review of non-surgical treatments for early dupuytren's disease.Dupuytren's Contracture in Alabama HFE Hemochromatosis Probands.Expression of VEGF, its receptors, and HIF-1α in Dupuytren's diseaseCollagenase Clostridium histolyticum: emerging practice patterns and treatment advances.Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren's contracture.Expression of gap junction proteins connexins 26, 30, and 43 in Dupuytren's disease.Evaluation of 5-fluorouracil pharmacokinetics in cancer patients with a c.1905+1G>A mutation in DPYD by means of a Bayesian limited sampling strategy.Dupuytren's disease presentation, referral pathways and resource utilisation in Europe: regional analysis of a surgeon survey and patient chart review.Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren's contractureDupuytren's disease therapy: targeting the vicious cycle of myofibroblasts?Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II.Molecular mechanisms and treatment strategies for Dupuytren's disease.Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.The quantitative role of flexor sheath incision in correcting Dupuytren proximal interphalangeal joint contractures.Embryonic Stem Cell-Like Population in Dupuytren's Disease Expresses Components of the Renin-Angiotensin System.Laminin-rich blood vessels display activated growth factor signaling and act as the proliferation centers in Dupuytren's contractureUnderstanding Dupuytren's Disease Using Systems Biology: A Move Away from Reductionism.Matrix and cell phenotype differences in Dupuytren's disease.Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases.Unité Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren's disease-specific disability.The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting.
P2860
Q28070387-DA7745BC-8208-4BBF-A556-771C9B9BEDC2Q30463808-FDE3DDF2-9D02-4F5A-B93E-8A750D11B673Q33686088-D38F6A6D-6E19-4DE9-8C66-1C0A15111398Q34249633-7B0A472E-C782-4089-A001-0F9DF8A08587Q34388383-ED02863E-3C73-4920-AF9F-4DFEC408A635Q34389581-BEFF985A-8CDE-4F61-BF25-284F251948BCQ34534498-9DECDC39-83F1-4548-82F5-A79743BFA0D2Q34534536-517AA8C6-2E04-4195-955C-7A22C2CA33CBQ34544470-1F47C5AC-7AD5-4670-8A50-39D215420A1CQ34648643-30702FB9-A83F-41D1-8988-31FD3D114BCAQ34975787-DA5DB04D-A780-4891-95FE-884A6B51EC7DQ35142313-ADC3579A-1959-4DF5-B07A-C58FEC292880Q35661449-B895E636-972D-43F9-AEF6-5FD410E4532BQ35800728-8E9B2A8F-2AB7-4334-931E-14ECA2C4EE5EQ35840713-8FE5A595-9E94-44E7-9B22-BBB73953E676Q36104328-AF1E5A82-115F-4029-B030-8FB1F8F87F83Q36202887-F9C49702-B7EC-40E3-85D3-F0D6465934CFQ37158416-1D6D64BE-78FC-4854-B397-A933D59F9ECCQ37300243-FDB582EC-56C8-4B19-AA61-8CAA1B753725Q37343413-CEBB35C3-975A-4729-80F5-0FC80EB316C4Q37614737-A9302272-BFBF-462C-9A89-CD0EA9B27897Q38001796-75F87389-0DB6-4E4F-9412-3B00F520D828Q38081467-D034CB09-72F1-4014-8ABD-F457E37F9540Q38201929-F422C843-C85E-41B8-B7BD-0F714229C05CQ38675433-425368C7-2A43-41B8-B442-5DCD59EED5ABQ39648906-69BFCB2E-3D3E-4D24-8427-79A60A2049B0Q39835520-C61BB24D-C0E8-4837-B1F0-892D59BEB95FQ40053230-CF238A64-2F0A-4691-9024-30AA82A03C65Q40310925-A5008D00-0EAD-405F-95F1-5F548916AC7EQ41306540-B663A4A1-C7B0-49F7-A78F-CBA58F6109C4Q42135329-A7DE4267-972F-4481-AC99-EBD40BBDE692Q42321526-AB8F57D1-53CA-4D61-9795-E2A7A0E7BF90Q42480775-D8CAA8F5-70DD-40B5-8CD9-26960137A9B9Q44902159-835648D1-587A-4436-95C8-039C0FE02114Q48823408-6AF085BF-50FC-4E7D-8EC1-5E00A63D8BE8Q55038674-08971285-79F9-48B5-A7FF-2A6A8EF4AFF7
P2860
Dupuytren disease: Anatomy, pathology, presentation, and treatment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Dupuytren disease: Anatomy, pathology, presentation, and treatment.
@ast
Dupuytren disease: Anatomy, pathology, presentation, and treatment.
@en
type
label
Dupuytren disease: Anatomy, pathology, presentation, and treatment.
@ast
Dupuytren disease: Anatomy, pathology, presentation, and treatment.
@en
prefLabel
Dupuytren disease: Anatomy, pathology, presentation, and treatment.
@ast
Dupuytren disease: Anatomy, pathology, presentation, and treatment.
@en
P1476
Dupuytren disease: Anatomy, pathology, presentation, and treatment.
@en
P2093
Ghazi M Rayan
P304
P356
10.2106/00004623-200701000-00026
P407
P577
2007-01-01T00:00:00Z